Clinical Trials Directory

Trials / Conditions / Unresectable Pancreatic Ductal Adenocarcinoma

Unresectable Pancreatic Ductal Adenocarcinoma

8 registered clinical trials studyying Unresectable Pancreatic Ductal Adenocarcinoma — 4 currently recruiting.

StatusTrialSponsorPhase
WithdrawnSTIL101 for Injection for the Treatment of Locally Advanced, Metastatic or Unresectable Pancreatic Cancer, Col
NCT06626256
City of Hope Medical CenterPhase 1
WithdrawnFL118 for Treating Patients With Advanced Pancreatic Ductal Adenocarcinoma
NCT06206876
Roswell Park Cancer InstitutePhase 1
RecruitingGemcitabine and Leflunomide in Patients With Advanced Unresectable Pancreatic Cancer
NCT06454383
City of Hope Medical CenterPhase 1
RecruitingCA-4948 Added to Standard Chemotherapy to Treat Metastatic or Unresectable Pancreatic Cancer
NCT05685602
National Cancer Institute (NCI)Phase 1
Active Not RecruitingSonoporation and Chemotherapy for the Treatment of Pancreatic Cancer
NCT04821284
Flemming ForsbergPhase 1 / Phase 2
RecruitingLenvatinib and Pembrolizumab Maintenance Therapy for the Treatment of Patients of Advanced Unresectable Pancre
NCT04887805
City of Hope Medical CenterPhase 2
RecruitingTargeted Pathway Inhibition in Patients With Pancreatic Cancer
NCT04005690
OHSU Knight Cancer InstituteEARLY_Phase 1
No Longer AvailableExpanded Access to Mifomelatide for Cachexia in Adults With Advanced PDAC
NCT07399015
Endevica Bio—